Lipohypertrophy: prevalence, clinical consequence, and pathogenesis
Open Access
- 17 August 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 134 (1), 47-49
- https://doi.org/10.1097/cm9.0000000000000970
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 28 references indexed in Scilit:
- Understanding Diabetic Foot Infection and its ManagementDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2017
- Clinical Update: Cardiovascular Disease in Diabetes MellitusCirculation, 2016
- Insulin amyloid at injection sites of patients with diabetesAmyloid, 2016
- A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetesSpringerPlus, 2016
- Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitusEye, 2016
- Concurrence of Lipoatrophy and Lipohypertrophy in Children With Type 1 Diabetes Using Recombinant Human Insulin: Two Case ReportsClinical Diabetes, 2016
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes AssociationDiabetes Care, 2015
- Prevalence of Lipohypertrophy and Associated Risk Factors in Insulin-Treated Patients With Type 2 Diabetes MellitusInternational Journal of Endocrinology and Metabolism, 2015
- Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015Indian Journal of Endocrinology and Metabolism, 2015
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetesDiabetes & Metabolism, 2013